Article Text

This article has a correction. Please see:

PDF
Modelling the transmission of HIV and HCV among injecting drug users in Rawalpindi, a low HCV prevalence setting in Pakistan
  1. P Vickerman,
  2. L Platt,
  3. S Hawkes
  1. London School of Hygiene and Tropical Medicine, London, UK
  1. Dr P Vickerman, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, UK; peter.vickerman{at}lshtm.ac.uk

Abstract

Background: In 2007, a survey in Rawalpindi found the prevalence of hepatitis C virus (HCV) in injecting drug users (IDUs) to be low (17%), despite widespread needle/syringe sharing. This analysis uses modelling to explore hypotheses for the low prevalence of HCV to project the future HIV/HCV epidemic and to estimate the impact of a generic intervention.

Methods: An HIV/HCV transmission model was developed and parameterised using data from Rawalpindi. By incorporating different assumptions about the relative frequency/importance of needle/syringe sharing events among “strangers” and people they have shared with before, and undertaking extensive uncertainty analyses to fit the model for each scenario, the validity of different hypotheses for the low HCV prevalence was determined. Model fits were used to project the future HIV/HCV epidemic and the impact of reducing needle/syringe sharing among different IDU subgroups.

Results: The model projections suggest that the low HCV prevalence in Rawalpindi is probably due to most HIV/HCV transmissions occurring in a small IDU subgroup that shares needles/syringes frequently with strangers, with most needle/syringe sharing incidents being low risk. Projections suggest that the prevalence of HIV in IDUs will increase to 5–12% by 2015, and the prevalence of HCV will increase if HIV increases HCV transmission. Moderate reductions in needle/syringe sharing (>40%) could reduce the number of HCV/HIV infections (∼45%) if all IDUs are reached, although less impact is achieved if high-risk IDUs are not reached.

Conclusions: Despite many needle/syringe sharing events possibly being low risk in Rawalpindi, the model projects that the prevalence of HIV/HCV in IDUs is likely to increase. This highlights the importance of intervening in this low prevalence setting.

Statistics from Altmetric.com

Footnotes

  • Additional material is published online only at http://sti.bmj.com/content/vol85/issueSupplII

  • Funding: Financial support was provided from the UK’s Department for International Development (DFID), a Medical Research Council New Investigators Award (held by PV) and the DFID-funded Research Programme Consortium for Research and Capacity Building in Sexual and Reproductive Health and HIV in Developing Countries of the London School of Hygiene and Tropical Medicine.

  • Competing interests: None.

  • Contributors: PV designed the study; LP and SH contributed to the study concept and designed the original data collection; LP undertook numerous epidemiological analyses; PV undertook all model analyses; all authors contributed to the interpretation of results and writing of the manuscript.

    The views expressed are those of the authors and cannot be taken to reflect the official opinions of the World Health Organization or the Department for International Development.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles

  • Correction
    BMJ Publishing Group Ltd